Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
ArrowMark Partners
AddedFeb 11, 2024
UpdatedJun 28, 2026
ArrowMark Partners

ArrowMark Partners

Operating

ArrowMark Partners: An employee-owned firm managing $19.5B in assets across diverse strategies since 2007.

Location
Denver, CO, US
Founded
2007
Firm
Compare
Portfolio
Employees
News
Website

ArrowMark Partners is an employee-owned asset management firm founded in 2007, managing $19.5 billion in assets. The firm focuses on alternative credit and capacity-constrained equity strategies, investing across various stages including Series A through Series G, with a notable presence in Series B and C rounds. ArrowMark's investment approach spans multiple sectors and geographies, catering to institutional clients and professional asset allocators.

Notable portfolio companies include Moderna, Dataminr, Ginkgo Bioworks, and SendGrid. Key partners at ArrowMark include Kaelyn Abrell, Sanjai Bhonsle, and founding partner David Corkins. The firm emphasizes a collaborative investment philosophy and offers unique value-add services such as regulatory capital relief and multi-sector credit investment strategies. ArrowMark's experienced team leverages their deep industry knowledge to support the growth and success of their portfolio companies.

ArrowMark Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments54
Current Portfolio Count38
Total Portfolio Exits2

Top Investment Stages

Series B19 (41.3%)
Series C13 (28.3%)
Series D5 (10.9%)
Series E5 (10.9%)
Post Ipo Equity4 (8.7%)

Stage Mix

Series B 41%Series C 28%Series D 11%Series E 11%Post Ipo Equity 9%

Concentration shown as share of disclosed investments by stage.

Recent Investments

SmartLabs logo

SmartLabs

Arvinas logo

Arvinas

Beta Bionics logo

Beta Bionics

Checkerspot logo

Checkerspot

Sonendo logo

Sonendo

Aktis Oncology logo

Aktis Oncology

Dren Bio logo

Dren Bio

Simcha Therapeutics logo

Simcha Therapeutics

Big Health logo

Big Health

Freenome logo

Freenome

Arbor Biotechnologies logo

Arbor Biotechnologies

Fyllo logo

Fyllo

Skyryse logo

Skyryse

TrialSpark logo

TrialSpark

Ginkgo Bioworks logo

Ginkgo Bioworks

Sonoma Biotherapeutics logo

Sonoma Biotherapeutics

Frontier Medicines logo

Frontier Medicines

Tvardi Therapeutics logo

Tvardi Therapeutics

Latch logo

Latch

Absci logo

Absci

Dataminr logo

Dataminr

Neurogene logo

Neurogene

Adagio Medical logo

Adagio Medical

Xometry logo

Xometry

Taysha Gene Therapies logo

Taysha Gene Therapies

ArrowMark Partners - Similar Investment Firms

Tru Arrow Partners logo

Tru Arrow Partners

truarrow.com

Arrow Venture Partners logo

Arrow Venture Partners

Xmark Asset Management logo

Xmark Asset Management

ArrowPath Venture Partners logo

ArrowPath Venture Partners

arrowpathvc.com

Archery Capital logo

Archery Capital

ARK Investment Management logo

ARK Investment Management

ark-invest.com

QuestMark Partners logo

QuestMark Partners

questm.com

ArmaVir Partners logo

ArmaVir Partners

Arosa Capital Management logo

Arosa Capital Management

arosacapital.com

StoneCastle Financial logo

StoneCastle Financial

Markpoint Venture Partners logo

Markpoint Venture Partners

Marcato Capital Management logo

Marcato Capital Management

Alpha Square Group logo

Alpha Square Group

Arrowroot Capital logo

Arrowroot Capital

Point72 Asset Management logo

Point72 Asset Management

point72.com

ArrowMark Partners - Classification

Also Known As
  • Arrowmark Asset Management, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions